by Raynovich Rod | Dec 16, 2014 | Biopharmaceuticals
Be defensive because the market knows not where it wants to go. It is so volatile that the CNBC-TV talking head was talking about the “rally”which at that time was already over! FINVIZ.com – Stock Screener Biotech is holding off its highs but the NAZ...
by Raynovich Rod | Dec 15, 2014 | Biopharmaceuticals
December 18 “Don’t Fight the Fed”-cliches still work. Biotechs roar back near YTD highs. Yellen calms volatile markets. Healthcare Stocks Not Immune To Bearish Mood Crude Hits Lowest Level in Five Years Biotech stocks joined the market sell-off...
by Raynovich Rod | Dec 11, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Part 1 Biopharmaceutical Stocks-New Highs Were Hit on December 10 Five Straight Years of Gains in Biotech-the IBB is up 292% since Dec 18, 2009 Biotech stocks are following the long term seasonal bullish trend surging in Q4 and up about 49 % YTD. The easiest way to...
by Raynovich Rod | Dec 10, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Macro
Crude Trade Roils Markets-But Biotech Is Still A Safe Haven Second Worst Week of the Year-Late Day Trading Hit By Selling As the market becomes more volatile we should look at how the energy trade is affecting other asset classes. Certainly materials and industrials...
by Raynovich Rod | Dec 8, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
Update 12/8 Biotech stocks hit new highs yesterday but could get choppy if overall market gets weak on bleak macro news. Cubist Pharmaceuticals (CBST) one of our original mid cap Biopharmaceutical picks soared 35% today to $100.75 on a $8.4B buyout by Merck (MRK)....
by Raynovich Rod | Dec 4, 2014 | Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update 12/12 Or Maybe NOT!! Jobs data tomorrow and most funds will ride their positions through year end. In the meantime it is a traders market. Update next week but review all our portfolio picks.
by Raynovich Rod | Dec 1, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Bounce Back Day 12/2/14 FBT up 1.5% to $102.33 Biotech players realized that news about China, energy and holiday shopping data do not affect their stocks. Our large cap biopharma portfolio went green helped by Biogen Idec (BIIB) up 6.43% on Phase 1a data for an...
by Raynovich Rod | Nov 26, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, 2024 Rayno Tools and Diagnostics Portfolio
NASDAQ leads -up 0.6% to 4787 The October correction of ~7% was a “headfake” as macro events scared many investor away Technology and Healthcare Stocks Lead The Way The healthcare SPDR (XLV) is up 24.5% YTD and the technology SPDR (XLK) is up 18% YTD....
by Raynovich Rod | Nov 17, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, 2024 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals
Update November 18 : NASDAQ 4702 up 0.67%, IBB at 295.25up 2.22% Recent Small Cap picks: CLDX 17.72 off 2.9% with profit taking.Very choppy trade. FCSC 2.67 flat little action, despite Press Release on amputee treatment. Foundation Medicine (FMI) at $25.86 up 2.67%....
by Raynovich Rod | Nov 14, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Red Tape Today Means Caution-Take Some Off XBI at $167.83 Off 2% Traders, investors, executives even pension funds are thrilled with biotech investing as the stock group rolls on to new highs this month. What may not be appreciated is the 20% move off the October 16...